Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study

摘要

AimDrug-induced liver injury (DILI) is often responsible for acute liver failure, drug withdrawal, boxed warnings or drug non-approval. Therefore, we conducted a case-control study to determine the hepatotoxic risk of a wide range of drugs.